Economic evaluation of general childhood vaccination against haemophilus influenzae type b in Sweden.
The objective of the study was to evaluate the economic consequences of a general childhood vaccination programme against Haemophilus influenzae type b (Hib) in Sweden.
A retrospective pre-vaccination annual cohort of 0-4-y-old children was compared with an annual cohort of the same age group after a complete implemented vaccination program against Hib.
The cost analysis shows that vaccination against Hib is cost saving when indirect costs are included in the analysis.
In the cost-benefit analysis it is shown that society will gain approximately 88 million Swedish Crowns (SEK) annually when Hib vaccination is totally implemented.
In conclusion, general childhood Hib vaccination is a cost-effective public health intervention in Swedish society.
Mots-clés Pascal : Haemophilus influenzae, Pasteurellaceae, Bactérie, Immunoprophylaxie, Aspect économique, Programme sanitaire, Analyse coût, Enfant, Homme, Vaccination, Suède, Europe, Analyse coût efficacité, Prévention, Economie santé
Mots-clés Pascal anglais : Haemophilus influenzae, Pasteurellaceae, Bacteria, Immunoprophylaxis, Economic aspect, Sanitary program, Cost analysis, Child, Human, Vaccination, Sweden, Europe, Cost efficiency analysis, Prevention, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0331430
Code Inist : 002B05B02B. Création : 27/11/1998.